跳到主要内容

新闻与日历

新闻: 截至 2026-10-06
这些标记是什么意思

重要性是模型对已发布报道给出的 1–5 分,不是对市场的预测。

已排定事件行上的影响是公司显著度层级(高/中由图谱中心度与规模判定;低仅用于人工整理的次要事件),不是对波动幅度的预测。

标记为已确认的财报日期,是 Yahoo Finance 认定由公司确认的;预估表示尚未公布。未加标记的行没有可查的出处记录。

经济数据发布属于宏观、不归属任何产业,因此在任何视图下都会保留。没有数值的发布表示尚未公布,页面会直说,而不是显示为零。

涵盖被追踪公司的即将到来的事件;已过去的事件会归档,并在可得时补上结果——这些结果都经人工整理并附引用,绝不杜撰。没有结果的历史行会显示“结果待定”。

解禁或指数调整的行会多出一行算术——将变得可卖出的股数,或指数基金必须买入的股数,以占流通股的比例表示——依据招股说明书或指数编制方法读出,两个数字都在该行注明出处。它陈述的是机制,不是价格走势。由 IPO + 180 天推算出的解禁日期会一直标为预估,直到公司自己说明为止。

未来

已排定 · 今天与明天 · 日历更新于 2026-10-12

10月12日周一 · 今天

10月13日周二

过往

已发布 · 最新在前

8月17日周一

监管

18:21
Business Wire

LYNKUET (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer

Bayer announced that Health Canada issued a Notice of Compliance expanding the indication for LYNKUET (elinzanetant) to the treatment of moderate to severe vasomotor symptoms caused by adjuvant endocrine therapy related to breast cancer, making it the first approved treatment option in Canada for that patient population. The expansion builds on Health Canada's July 2025 authorization of LYNKUET for moderate to severe VMS associated with menopause and was supported by Bayer's OASIS-4 study. LYNKUET is a once-daily oral, non-hormonal dual neurokinin-targeted therapy antagonizing both NK-1 and NK-3 receptors.

大盘 打开原文 ↗

人事

17:27
Spectrum News 13

United Launch Alliance names Mark Peller president and CEO

United Launch Alliance named Mark Peller president and chief executive officer, with the new role starting immediately. Peller was previously chief operating officer overseeing Atlas and Vulcan rocket operations and joined ULA at its formation in 2006. He replaces interim CEO John Elbon, who stepped in after Tory Bruno left eight months earlier to lead Blue Origin's National Security Group. ULA is a joint venture whose board chair is Robert Lightfoot, president of Lockheed Martin Space, with Boeing represented by Kay Sears, vice president and general manager of Space, Intelligence & Weapon Systems.

大盘 打开原文 ↗

财报

12:21
GlobeNewswire

Novo Nordisk A/S - share repurchase programme

Novo Nordisk filed its weekly buyback disclosure. The overall programme is for up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026, with the current tranche of up to DKK 11,200,000,010.45 running from 6 May 2026 to 1 February 2027. In the 10-14 August 2026 window the company repurchased 1,000,000 B shares, bringing the cumulative total under the tranche to 14,125,000 B shares for DKK 4,281,660,830. Following the transactions Novo Nordisk holds 42,924,876 B shares of DKK 0.10 as treasury shares, corresponding to 1.0% of the share capital.

大盘 打开原文 ↗

合作

12:10
Yahoo Finance

RTX's Raytheon awarded $22.9 billion seven-year Tomahawk production contract

Raytheon, an RTX business, was awarded a $22.9 billion, seven-year contract by the U.S. Department of War covering an annual production ramp to more than 1,000 Tomahawk missiles and associated support. RTX said it delivered three times more Tomahawks in the first half of 2026 than in the same period of 2025. Raytheon President Phil Jasper said "Tomahawk is the Navy's most important strike weapon, able to target hostile forces hundreds of miles away without ever risking the lives of our sailors."

大盘 打开原文 ↗

人事

11:30
L3Harris Technologies

L3Harris removes CEO Chris Kubasik over conduct, names Sam Mehta president and CEO

L3Harris Technologies appointed Sam Mehta as President and Chief Executive Officer and a member of the Board, effective immediately, after the board identified certain conduct by Chris Kubasik that was not consistent with the values of the company as outlined in its Code of Conduct — conduct L3Harris said was unrelated to financial reporting, controls, customer relationships or operational performance. Lead Independent Director Lewis Hay III was named Independent Chairman of the Board. Mehta most recently led the Space & Mission Systems and Communications & Spectrum Dominance segments and previously held leadership positions at Collins Aerospace and Sikorsky Aircraft. L3Harris reaffirmed its 2026 consolidated revenue, organic growth, segment operating margin, GAAP earnings per share and free cash flow.

大盘 打开原文 ↗

原始消息流

所有到达的消息 · 7 天